Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)

ClinicalTrials.gov ID: NCT05966155

Public ClinicalTrials.gov record NCT05966155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Depression and Opioid Pragmatic Trial in Pharmacogenetics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and the trial design. The three trials are the Acute Pain Trial, the Chronic Pain Trial, and the Depression Trial. Participants can enroll in only one of the three trials. All three trials were registered on ClinicalTrials.gov under NCT04445792. In July 2023 each of the three treatment trials was registered under a separate NCT# and NCT04445792 was converted to a screening record per recent guidance on master protocol research programs (MPRPs). This record is specific to the Depression Trial within the ADOPT-PGx protocol. The Depression Trial is a prospective, multicenter, two arm randomized pragmatic trial. Participants meeting eligibility criteria will be randomly assigned to either immediate pharmacogenetic testing and genotype-guided anti-depressant therapy (Intervention arm) or standard care with 6-month delayed pharmacogenetic testing (Control arm). The investigators will test the hypothesis that pharmacogenetic testing and genotype-guided anti-depressant therapy will reduce depression symptoms in participants who's body processes some anti-depressants faster or slower than normal.

Study identification

NCT ID
NCT05966155
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Duke University
Other
Enrollment
1,572 participants

Conditions and interventions

Eligibility (public fields only)

Age range
8 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 9, 2021
Primary completion
Apr 26, 2024
Completion
Apr 26, 2024
Last update posted
Jun 28, 2025

2021 – 2024

United States locations

U.S. sites
14
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Nemours Children's Health System Wilmington Delaware 19803
University of Florida - Gainesville Gainesville Florida 32610
Nemours Children's Health System Jacksonville Florida 32207
University of Florida - Jacksonville Jacksonville Florida 32209
Nemours Children's Health System Orlando Florida 32827
Eskenazi Health Indianapolis Indiana 46202
Indiana University Indianapolis Indiana 46202
Icahn School of Medicine at Mount Sinai New York New York 10029
The Institute for Family Health New York New York 10035
Duke University Medical Center Durham North Carolina 27710
Sanford Health Fargo North Dakota 58104
Meharry Medical College Nashville Tennessee 37208
Nashville General Hospital Nashville Tennessee 37208
Vanderbilt University Medical Center Nashville Tennessee 37232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Depression trials

Other public records listing Depression. Sorted by last update posted; newest first. Not a recommendation.

All Depression trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05966155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2025 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05966155 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →